Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

References for PMC Articles for PubMed (Select 22484813)

1.

Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation.

Sangwan M, McCurdy SR, Livne-Bar I, Ahmad M, Wrana JL, Chen D, Bremner R.

Oncogene. 2012 Nov 29;31(48):5019-28. doi: 10.1038/onc.2011.654. Epub 2012 Jan 30.

PMID:
22286767
2.

Coexpression of normally incompatible developmental pathways in retinoblastoma genesis.

McEvoy J, Flores-Otero J, Zhang J, Nemeth K, Brennan R, Bradley C, Krafcik F, Rodriguez-Galindo C, Wilson M, Xiong S, Lozano G, Sage J, Fu L, Louhibi L, Trimarchi J, Pani A, Smeyne R, Johnson D, Dyer MA.

Cancer Cell. 2011 Aug 16;20(2):260-75. doi: 10.1016/j.ccr.2011.07.005.

3.

miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.

Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM, MacPherson D.

Genes Dev. 2011 Aug 15;25(16):1734-45. doi: 10.1101/gad.17027411. Epub 2011 Aug 4.

4.

Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells.

Churchman ML, Roig I, Jasin M, Keeney S, Sherr CJ.

PLoS Genet. 2011 Jul;7(7):e1002157. doi: 10.1371/journal.pgen.1002157. Epub 2011 Jul 21.

5.

Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.

Brennan RC, Federico S, Bradley C, Zhang J, Flores-Otero J, Wilson M, Stewart C, Zhu F, Guy K, Dyer MA.

Cancer Res. 2011 Jun 15;71(12):4205-13. doi: 10.1158/0008-5472.CAN-11-0058. Epub 2011 Apr 22.

6.

Widespread overexpression of epitope-tagged Mdm4 does not accelerate tumor formation in vivo.

De Clercq S, Gembarska A, Denecker G, Maetens M, Naessens M, Haigh K, Haigh JJ, Marine JC.

Mol Cell Biol. 2010 Nov;30(22):5394-405. doi: 10.1128/MCB.00330-10. Epub 2010 Sep 20.

7.

The senescence-associated secretory phenotype: the dark side of tumor suppression.

Coppé JP, Desprez PY, Krtolica A, Campisi J.

Annu Rev Pathol. 2010;5:99-118. doi: 10.1146/annurev-pathol-121808-102144. Review.

8.

Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo.

Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O.

Nat Protoc. 2009;4(12):1798-806. doi: 10.1038/nprot.2009.191. Epub .

PMID:
20010931
9.

Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling.

Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D, Liu A, Jhanwar SC, Abramson DH, Cobrinik D.

Cell. 2009 Jun 12;137(6):1018-31. doi: 10.1016/j.cell.2009.03.051.

10.

Cellular mechanisms of tumour suppression by the retinoblastoma gene.

Burkhart DL, Sage J.

Nat Rev Cancer. 2008 Sep;8(9):671-82. doi: 10.1038/nrc2399. Review.

PMID:
18650841
11.

Insights from mouse models into human retinoblastoma.

Macpherson D.

Cell Div. 2008 May 19;3:9. doi: 10.1186/1747-1028-3-9.

12.

Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.

Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC Jr, Squire JA, Gallie BL.

Hum Mol Genet. 2008 May 15;17(10):1363-72. doi: 10.1093/hmg/ddn024. Epub 2008 Jan 22.

13.

One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma.

Corson TW, Gallie BL.

Genes Chromosomes Cancer. 2007 Jul;46(7):617-34. Review.

PMID:
17437278
14.

Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification.

MacPherson D, Conkrite K, Tam M, Mukai S, Mu D, Jacks T.

EMBO J. 2007 Feb 7;26(3):784-94. Epub 2007 Jan 18.

15.

Inactivation of the p53 pathway in retinoblastoma.

Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, Teunisse A, Lam S, Ramos Y, Mohan A, Johnson D, Wilson M, Rodriguez-Galindo C, Quarto M, Francoz S, Mendrysa SM, Guy RK, Marine JC, Jochemsen AG, Dyer MA.

Nature. 2006 Nov 2;444(7115):61-6.

PMID:
17080083
16.

Divorcing ARF and p53: an unsettled case.

Sherr CJ.

Nat Rev Cancer. 2006 Sep;6(9):663-73. Epub 2006 Aug 17. Review.

PMID:
16915296
17.

Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimens.

Lakshmi B, Hall IM, Egan C, Alexander J, Leotta A, Healy J, Zender L, Spector MS, Xue W, Lowe SW, Wigler M, Lucito R.

Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11234-9. Epub 2006 Jul 14.

18.

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.

Liu Y, Bodmer WF.

Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):976-81. Epub 2006 Jan 17.

19.

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T.

Cell. 2004 Dec 17;119(6):847-60.

PMID:
15607980
20.

Cell type-specific effects of Rb deletion in the murine retina.

MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME, Jacks T.

Genes Dev. 2004 Jul 15;18(14):1681-94. Epub 2004 Jul 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk